Trial Profile
Double-Masked Parallel Evaluation of the Safety and Efficacy of Phentolamine Mesylate Ophthalmic Solution in Subjects With Severe Night Vision Disturbances
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 02 Aug 2019
Price :
$35
*
At a glance
- Drugs Phentolamine (Primary)
- Indications Nyctalopia
- Focus Therapeutic Use
- Sponsors Ocuphire Pharma
- 22 Jul 2019 According to an Ocuphire Pharma media release, results from this trial were presented at the American Academy of Ophthalmology Annual Meeting in October 2018 and at the Ophthalmology Innovation Summit in May 2019.
- 08 Dec 2015 New trial record